| Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ... International journal of antimicrobial agents 56 (1), 105949, 2020 | 6512 | 2020 |
| Microbial culturomics: paradigm shift in the human gut microbiome study JC Lagier, F Armougom, M Million, P Hugon, I Pagnier, C Robert, F Bittar, ... Clinical Microbiology and Infection 18 (12), 1185-1193, 2012 | 1211 | 2012 |
| Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 P Colson, JM Rolain, JC Lagier, P Brouqui, D Raoult International journal of antimicrobial agents 55 (4), 105932, 2020 | 1169 | 2020 |
| Culture of previously uncultured members of the human gut microbiota by culturomics JC Lagier, S Khelaifia, MT Alou, S Ndongo, N Dione, P Hugon, A Caputo, ... Nature microbiology 1 (12), 2016 | 929 | 2016 |
| Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study P Gautret, JC Lagier, P Parola, L Meddeb, J Sevestre, M Mailhe, ... Travel medicine and infectious disease 34, 101663, 2020 | 919 | 2020 |
| The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota JC Lagier, P Hugon, S Khelaifia, PE Fournier, B La Scola, D Raoult Clinical microbiology reviews 28 (1), 237-264, 2015 | 800 | 2015 |
| Culturing the human microbiota and culturomics JC Lagier, G Dubourg, M Million, F Cadoret, M Bilen, F Fenollar, ... Nature Reviews Microbiology 16 (9), 540-550, 2018 | 701 | 2018 |
| Current and past strategies for bacterial culture in clinical microbiology JC Lagier, S Edouard, I Pagnier, O Mediannikov, M Drancourt, D Raoult Clinical microbiology reviews 28 (1), 208-236, 2015 | 599 | 2015 |
| Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France M Million, JC Lagier, P Gautret, P Colson, PE Fournier, S Amrane, ... Travel medicine and infectious disease 35, 101738, 2020 | 568 | 2020 |
| A polyphasic strategy incorporating genomic data for the taxonomic description of novel bacterial species D Ramasamy, AK Mishra, JC Lagier, R Padhmanabhan, M Rossi, ... International journal of systematic and evolutionary microbiology 64 (Pt_2 …, 2014 | 448 | 2014 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 437 | 2021 |
| Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization–time of flight mass spectrometry P Seng, C Abat, JM Rolain, P Colson, JC Lagier, F Gouriet, PE Fournier, ... Journal of clinical microbiology 51 (7), 2182-2194, 2013 | 434 | 2013 |
| Human gut microbiota: repertoire and variations JC Lagier, M Million, P Hugon, F Armougom, D Raoult Frontiers in cellular and infection microbiology 2, 136, 2012 | 370 | 2012 |
| Gut bacterial microbiota and obesity M Million, JC Lagier, D Yahav, M Paul Clinical Microbiology and Infection 19 (4), 305-313, 2013 | 348 | 2013 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 325 | 2021 |
| Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology M Bonnet, JC Lagier, D Raoult, S Khelaifia New microbes and new infections 34, 100622, 2020 | 307 | 2020 |
| Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis JC Lagier, M Million, P Gautret, P Colson, S Cortaredona, ... Travel medicine and infectious disease 36, 101791, 2020 | 300 | 2020 |
| Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center JC Lagier, H Lepidi, D Raoult, F Fenollar Medicine 89 (5), 337-345, 2010 | 261 | 2010 |
| Gut microbiota diversity according to dietary habits and geographical provenance B Senghor, C Sokhna, R Ruimy, JC Lagier Human Microbiome Journal 7, 1-9, 2018 | 243 | 2018 |
| High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment G Dubourg, JC Lagier, F Armougom, C Robert, G Audoly, L Papazian, ... International journal of antimicrobial agents 41 (2), 149-155, 2013 | 224 | 2013 |
